149 related articles for article (PubMed ID: 33465826)
21. Mechanisms of responsiveness to and resistance against trabectedin in murine models of human myxoid liposarcoma.
Mannarino L; Craparotta I; Ballabio S; Frapolli R; Meroni M; Bello E; Panini N; Callari M; Sanfilippo R; Casali PG; Barisella M; Fabbroni C; Marchini S; D'Incalci M
Genomics; 2021 Sep; 113(5):3439-3448. PubMed ID: 34339817
[TBL] [Abstract][Full Text] [Related]
22. The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells.
Engström K; Willén H; Kåbjörn-Gustafsson C; Andersson C; Olsson M; Göransson M; Järnum S; Olofsson A; Warnhammar E; Aman P
Am J Pathol; 2006 May; 168(5):1642-53. PubMed ID: 16651630
[TBL] [Abstract][Full Text] [Related]
23. Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development.
Ranji P; Jonasson E; Andersson L; Filges S; Luna Santamaría M; Vannas C; Dolatabadi S; Gustafsson A; Myklebost O; Håkansson J; Fagman H; Landberg G; Åman P; Ståhlberg A
J Transl Med; 2024 Apr; 22(1):389. PubMed ID: 38671504
[TBL] [Abstract][Full Text] [Related]
24. FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma.
Trautmann M; Menzel J; Bertling C; Cyra M; Isfort I; Steinestel K; Elges S; Grünewald I; Altvater B; Rossig C; Fröhling S; Hafner S; Simmet T; Åman P; Wardelmann E; Huss S; Hartmann W
Clin Cancer Res; 2017 Oct; 23(20):6227-6238. PubMed ID: 28637688
[No Abstract] [Full Text] [Related]
25. Fine-needle aspiration biopsy of myxoid liposarcoma metastatic to the liver: cytomorphologic and cytogenetic features.
Elwood H; Parwani A; Cai G
Diagn Cytopathol; 2007 Nov; 35(11):734-7. PubMed ID: 17924413
[TBL] [Abstract][Full Text] [Related]
26. Regulatory mechanisms, expression levels and proliferation effects of the FUS-DDIT3 fusion oncogene in liposarcoma.
Åman P; Dolatabadi S; Svec D; Jonasson E; Safavi S; Andersson D; Grundevik P; Thomsen C; Ståhlberg A
J Pathol; 2016 Apr; 238(5):689-99. PubMed ID: 26865464
[TBL] [Abstract][Full Text] [Related]
27. Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1-DDIT3 fusion.
Bode-Lesniewska B; Frigerio S; Exner U; Abdou MT; Moch H; Zimmermann DR
Genes Chromosomes Cancer; 2007 Nov; 46(11):961-71. PubMed ID: 17647282
[TBL] [Abstract][Full Text] [Related]
28. Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features.
Boland JM; Colby TV; Folpe AL
Am J Surg Pathol; 2012 Sep; 36(9):1395-403. PubMed ID: 22895273
[TBL] [Abstract][Full Text] [Related]
29. Metastasis of myxoid liposarcoma to fat-bearing areas: A case report of unusual metastatic sites and a hypothesis.
Lin S; Gan Z; Han K; Yao Y; Min D
Oncol Lett; 2015 Oct; 10(4):2543-2546. PubMed ID: 26622886
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the diagnostic performances of core needle biopsy in myxoid versus non-myxoid tumors.
Rohela H; Lee C; Yoo HJ; Kim HS; Kim Y; Cho HS; Han I
Eur J Surg Oncol; 2019 Jul; 45(7):1293-1298. PubMed ID: 31085026
[TBL] [Abstract][Full Text] [Related]
31. [Myxoid liposarcoma].
Douchamps F; Kurth W; Crielaard JM
Rev Med Liege; 2009; 64(7-8):403-6. PubMed ID: 19777921
[TBL] [Abstract][Full Text] [Related]
32. Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations.
Hoffman A; Ghadimi MP; Demicco EG; Creighton CJ; Torres K; Colombo C; Peng T; Lusby K; Ingram D; Hornick JL; Wang WL; Ravi V; Lazar AJ; Lev D; Pollock RE
Cancer; 2013 May; 119(10):1868-77. PubMed ID: 23401071
[TBL] [Abstract][Full Text] [Related]
33. Myxoid liposarcoma of the ankle.
Werd MB; DeFronzo DJ; Landsman AS; Surprenant M; Sakoff M
J Foot Ankle Surg; 1995; 34(5):465-74. PubMed ID: 8590881
[TBL] [Abstract][Full Text] [Related]
34. GLI1-Altered Soft Tissue Tumors of the Head and Neck: Frequent Oropharyngeal Involvement, p16 Immunoreactivity, and Detectable Alterations by DDIT3 Break Apart FISH.
Palsgrove DN; Rooper LM; Stevens TM; Shin C; Damm DD; Gagan J; Bridge JA; Thompson LDR; Koduru PR; Bishop JA
Head Neck Pathol; 2022 Dec; 16(4):1146-1156. PubMed ID: 35933574
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic utility of NCOA2 fluorescence in situ hybridization and Stat6 immunohistochemistry staining for soft tissue angiofibroma and morphologically similar fibrovascular tumors.
Sugita S; Aoyama T; Kondo K; Keira Y; Ogino J; Nakanishi K; Kaya M; Emori M; Tsukahara T; Nakajima H; Takagi M; Hasegawa T
Hum Pathol; 2014 Aug; 45(8):1588-96. PubMed ID: 24856853
[TBL] [Abstract][Full Text] [Related]
36. Myxoid liposarcoma with cartilaginous differentiation: A case study with fish analysis and review of the literature.
Ioannou MG; Kouvaras E; Papamichali R; Karachalios T; Koukoulis G
Pathol Res Pract; 2013 Oct; 209(10):666-9. PubMed ID: 23920321
[TBL] [Abstract][Full Text] [Related]
37. [Diagnostic value of ultrasound-guided core needle biopsy for soft tissue tumors].
Na J; Fang ZW; Zhao AL; Li JY
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):158-62. PubMed ID: 23769433
[TBL] [Abstract][Full Text] [Related]
38. Myxoid liposarcoma of the retropatellar fat pad.
Lundy DW; Aboulafia AJ; Otis JB; Fuller TR; Ogden JA
Am J Orthop (Belle Mead NJ); 1997 Apr; 26(4):287-9. PubMed ID: 9113297
[TBL] [Abstract][Full Text] [Related]
39. The expanded histologic spectrum of myxoid liposarcoma with an emphasis on newly described patterns: implications for diagnosis on small biopsy specimens.
Fritchie KJ; Goldblum JR; Tubbs RR; Sun Y; Carver P; Billings SD; Rubin BP
Am J Clin Pathol; 2012 Feb; 137(2):229-39. PubMed ID: 22261448
[TBL] [Abstract][Full Text] [Related]
40. The value of fine-needle aspiration biopsy in the differential diagnosis of adult myxoid sarcoma.
Kilpatrick SE; Ward WG; Bos GD
Cancer; 2000 Jun; 90(3):167-77. PubMed ID: 10896330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
